Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03134716 : Role of Microglia in the Pathogenesis of Progressive Multiple Sclerosis
AgesMin: 40 Years Max: 50 Years
Inclusion Criteria:

- RRMS, age 40-50 years, MS-diagnosis for a minimum of five years.

Exclusion Criteria:

- Previous or present treatment with immunosuppressive medication or biologicals. -
Steroid treatment within 30 days of evaluation
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557